Clinical Trial Update: Continuous Cellsaver and Neurocognitive Decline Post Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the use of a continuous cellsaver during cardiac surgery has completed. The study examined neurocognitive decline as an outcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Neurocognitive Disorder

Snippet

Sponsor: University Health Network, Toronto | Conditions: Heart Disease, Neurocognitive Decline | Phase 4 | Status: COMPLETED